{"name":"Creative Medical Technology Holdings Inc","slug":"creative-medical-technology-holdings-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CELZ-201-DDT","genericName":"CELZ-201-DDT","slug":"celz-201-ddt","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"CELZ-201-DDT","genericName":"CELZ-201-DDT","slug":"celz-201-ddt","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"earnings","source":"simplywall.st","summary":"When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - simplywall.st","headline":"When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOLXRmVTFCLV9jS3k3MlBpdElJVnJqd051SWhkWE04N3UtWjc0NnNBaDJNSDl1bUNFdFdxRGU0Tk1mVENZdmRaZi0tTXp4Rk0yQ0QwNldYem5VaHRTajM5V0hkVGZGd2pCbURUYk9HeUs0dFpqcV81b1E0U2JsaVl5TFFiZzB1ZENIeGVJRWJKd3JpejE5OUdOVWNET3dOc2Y4TVkxMjJJZWtvWVVraVVYYnVMcHF1dEhFMy1JSFJHUHMxaW1NLXc?oc=5","date":"2026-03-20","type":"trial","source":"Stock Titan","summary":"Creative Medical (NASDAQ: CELZ) details 2025 losses and regenerative trial progress - Stock Titan","headline":"Creative Medical (NASDAQ: CELZ) details 2025 losses and regenerative trial progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","date":"2026-03-05","type":"deal","source":"Morningstar","summary":"The Best Healthcare Stocks to Buy - Morningstar","headline":"The Best Healthcare Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQWHd2bm9uTndQckh3cDZScnZ4Z0lUVUZUSDliUmhyNDIzWHJlNjZJajAxVWF3WGZaa040YmZOTHpOcERscmtxeURuV3A2ZzkwaG9TWVNRaXdXYUloSFQ3YlowWWg0eGJzdnF0M1pWX2RqY1NmZnlmbWVmYjYtMzFSeVQzRXdjR1k?oc=5","date":"2026-02-10","type":"pipeline","source":"Quiver Quantitative","summary":"Creative Medical Technology Holdings, Inc. Achieves Milestone with WHO for Second INN Recognition of CELZ-101 - Quiver Quantitative","headline":"Creative Medical Technology Holdings, Inc. Achieves Milestone with WHO for Second INN Recognition of CELZ-101","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNUnBjRTlPbHhZWkt1RnVpMnRnM0R4SmI0aHM0b2RoQkFtLU5MNlhsSjV3YVI1cU1QVmRZd0pHSVFuZjg3cUJQcXhsYkZXN3ZDNWl2a0tZdU1yTUxmY2N0dHJCMWhTcTUwMUJYZVFYNG9ZYUhySmxXdVZneHU0VzFHVHJxNHRQOFgteDFoVk1OYjAwMDREcTZPbFVobEY3dTlXOVk3SkFfZEdkbHkyVGp3Y0JtYl85R3hxNjY2cFg1bw?oc=5","date":"2026-02-10","type":"pipeline","source":"Investing.com","summary":"Creative Medical receives WHO designation for second cell therapy - Investing.com","headline":"Creative Medical receives WHO designation for second cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbUpHSDlGME9JUjVEdnhlUjhNTW1zWUVqNVQ0cFE5cHdpSTZXWDJ6ekFnUHEzdWNtbmpta2pHRTl3M3ZtNHRZbmxTN3AtQm1UTE1GVXNkYi1mQW9Ga1JoYjlmY0FLVk4ta1RNcWgzRUVsVlFMdk5mZlNiZUhKWHFrUTU5TTVQY1hibnJBczFGUHp1bEtnOWtRejFONnFndDdWUDJzMlUtb0YzRXBRa0tPdWlyMXJyUQ?oc=5","date":"2026-02-10","type":"pipeline","source":"Stock Titan","summary":"Two Creative Medical cell therapies gain WHO naming milestones - Stock Titan","headline":"Two Creative Medical cell therapies gain WHO naming milestones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNZkhSN2s4dEFsc1Y4UUNZaHB1TUZQTjJoLUJLT21vc1ByY0ZyN3hYVTdWUVZHZ1pIV21BbGpiYlI4bnlnZzkta3hvZFFrYy04UURBNXU0Y0QwZGdXUS1hcm1zZ1JnVHBNUkZ1S2FZWmEycFBLOERjZGRGT3ZKMVU3OHpld3drdnMwOERRNGVsaU5PMVJmTDZaWks2V1N2Q1Z4Q2p6UnhvTHFyQjBOUGRBcDdOX24?oc=5","date":"2025-12-02","type":"pipeline","source":"Stock Titan","summary":"Creative Medical (NASDAQ: CELZ) gets WHO INN 'olastrocel' for CELZ-201 cell therapy - Stock Titan","headline":"Creative Medical (NASDAQ: CELZ) gets WHO INN 'olastrocel' for CELZ-201 cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQMXpLRDFGX1BwbjZldk1tNjN2QXJQclRZVVBmYjhVQUo2LUlFVWNySEdxdVk5dGxud3hibTN6TUdRa2RZWkJ4Umw4SG9GWU5mZmthUlhsV2lCeWRWaWZqX29CeGtxeml3cWNybnI3eVZfaHUxbmNnZXlJa1dpeVVUX2xYY3dLcnVWYzRoMkJSYXdrY0F5bnJSWE1ibEFob242THNRbF83Z0VTSG5V?oc=5","date":"2025-10-27","type":"trial","source":"Stock Titan","summary":"Creative Medical (NASDAQ: CELZ) targets H1 2026 data from ADAPT; secures 2 U.S. patents - Stock Titan","headline":"Creative Medical (NASDAQ: CELZ) targets H1 2026 data from ADAPT; secures 2 U.S. patents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ3M2WFZiNFBib21LZzY1QmJkSVZGM2U0Y1lISEhaVHZXeEVDWGg1VWozVy0wWHNiTTBKd1JlZVQtS09leFJBTHNYZ1kyVDhFdTZWbUl4RV9NQWdrcVFZRVNUOGtMMTZIakJqRzFETkVoT2FBbmQ5dVNjb3ZWd2JrTTcxTFlEYXl6eFVMTDBHYlM3Y3ZtbU4waFJad0dueHpTZVVkeGpiVW1sZ1VSMUMtZ1FRREowSUE?oc=5","date":"2025-05-12","type":"pipeline","source":"Seeking Alpha","summary":"Creative Medical Technology Holdings: Initiating Coverage With A Sell Rating - Seeking Alpha","headline":"Creative Medical Technology Holdings: Initiating Coverage With A Sell Rating","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOLWkwYUNVQ3ZsYjIxMjNhMk9ZaFlZMjAzelJIalp5RkRpdWRFZHJqc3FOeVFaTi1WakJvNTZDa1BQbmh3VmwzSjRSemlHaXpYMVVtc3JFNkhRYWlOSDFuQ2dsZ3NnSjVTUnNVWXNmNlppYWV3anhOcFU1QXlpQjk4aW8xdW13RnJ6QXNzMmk2YlVGdnRtSG1QdFlYVk1kQVkxb0ZBY0hlT1FEVnNiLWo4M2VVbnU?oc=5","date":"2025-03-25","type":"deal","source":"Nasdaq","summary":"Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - Nasdaq","headline":"Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNUEg4azdva2JrYVJpeGh5SEdUcVc2YlRDbnd1OEQwYkJqdV9RYnFqai1SblR3TmJkMDdnS1BPek1HdW5vZm1JY0hIUkJBdE91MU8yMjR3eUsteEpzbW9CaXRMZUtUTnlpZVBHUzVEaUdSUEYzN2VBUDNtMXpnTjhCLXh2bzd2Ulg1ZFdsMGNMclFvVEtSTmpablRLMEQ5NDkzUkl3WnZQaXRHWEpsU0EzTGpIaTVqNDdWbEE?oc=5","date":"2023-06-12","type":"pipeline","source":"PR Newswire","summary":"Creative Medical Technology Holdings Provides Corporate Update - PR Newswire","headline":"Creative Medical Technology Holdings Provides Corporate Update","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}